Author: Andrews, Denise; Chetty, Yumela; Cooper, Ben S.; Virk, Manjinder; Glass, Stephen K; Letters, Andrew; Kelly, Philip A.; Sudhanva, Malur; Jeyaratnam, Dakshika
Title: Multiplex PCR point of care testing versus routine, laboratory-based testing in the treatment of adults with respiratory tract infections: a quasi-randomised study assessing impact on length of stay and antimicrobial use Document date: 2017_10_10
ID: 1sdt9zz8_34
Snippet: POC testing was associated with a reduction in time to antivirals for those identified with influenza virus. Antivirals were given a day and a half quicker in the intervention arm and within a day of admission. Given that these drugs are of clinical benefit only if administered within 48 h of symptom onset [4] , this is a key, clinical outcome. POC testing allowed changes to therapy for the appropriate treatment of mycoplasma infection; in the co.....
Document: POC testing was associated with a reduction in time to antivirals for those identified with influenza virus. Antivirals were given a day and a half quicker in the intervention arm and within a day of admission. Given that these drugs are of clinical benefit only if administered within 48 h of symptom onset [4] , this is a key, clinical outcome. POC testing allowed changes to therapy for the appropriate treatment of mycoplasma infection; in the control arm, positive results were uninterpretable and were predominantly available after discharge. The ability of FilmArray® to detect coronaviruses allowed for a diagnosis to be made in 15 samples that would have been missed using routine methods. Routine testing only identified single pathogens as opposed to FilmArray® which identified dual infection in 5 patients, of importance for infection control and virus surveillance. Parainfluenza virus types 1, 2 and 4, Chlamydia pneumoniae and Bordetella pertussis were not detected during the course of this study which did not span the entire winter.
Search related documents:
Co phrase search for related documents- admission day and Bordetella pertussis: 1, 2
- admission day and Chlamydia pneumoniae: 1, 2, 3
- admission day and clinical benefit: 1, 2, 3
- admission day and clinical outcome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- admission day and control arm: 1, 2, 3, 4
- admission day and half day: 1, 2, 3
- admission day and infection control: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- admission day and influenza virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- antiviral time reduction and influenza virus: 1
- appropriate treatment and Bordetella pertussis: 1
- appropriate treatment and Chlamydia pneumoniae: 1, 2
- appropriate treatment and clinical benefit: 1, 2, 3
- appropriate treatment and clinical outcome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
- appropriate treatment and control arm: 1, 2, 3, 4
- appropriate treatment and infection control: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- appropriate treatment and influenza virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
- Bordetella pertussis and clinical outcome: 1, 2
- Bordetella pertussis and infection control: 1, 2, 3, 4
- Bordetella pertussis and influenza virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
Co phrase search for related documents, hyperlinks ordered by date